Cover Image

Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis

To explore the prognostic value of serial dynamic contrast-enhanced (DCE) MRI in patients with advanced pulmonary adenocarcinoma undergoing first-line therapy with either tyrosine-kinase inhibitors (TKI) or platinum-based chemotherapy (PBC).

Saved in:
Bibliographic Details
Main Authors: Rheinheimer, Stephan (Author) , Christopoulos, Petros (Author) , Erdmann, Stella (Author) , Saupe, Julia (Author) , Golpon, Heiko André (Author) , Vogel-Claussen, Jens (Author) , Dinkel, Julien (Author) , Thomas, Michael (Author) , Heußel, Claus Peter (Author) , Kauczor, Hans-Ulrich (Author) , Heußel, Gudula (Author)
Format: Article (Journal)
Language:English
Published: 05 December 2022
In: BMC medical imaging
Year: 2022, Volume: 22, Pages: 1-12
ISSN:1471-2342
DOI:10.1186/s12880-022-00943-x
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12880-022-00943-x
Verlag, kostenfrei, Volltext: https://bmcmedimaging.biomedcentral.com/articles/10.1186/s12880-022-00943-x
Get full text
Author Notes:Stephan Rheinheimer, Petros Christopoulos, Stella Erdmann, Julia Saupe, Heiko Golpon, Jens Vogel-Claussen, Julien Dinkel, Michael Thomas, Claus Peter Heussel, Hans-Ulrich Kauczor and Gudula Heussel
Description
Summary:To explore the prognostic value of serial dynamic contrast-enhanced (DCE) MRI in patients with advanced pulmonary adenocarcinoma undergoing first-line therapy with either tyrosine-kinase inhibitors (TKI) or platinum-based chemotherapy (PBC).
Item Description:Gesehen am 08.11.2023
Physical Description:Online Resource
ISSN:1471-2342
DOI:10.1186/s12880-022-00943-x

Similar Items